A Phase I/II, Single Center, Proof-of-Concept Study of Birinapant in Combination With Platinum Based Chemotherapy Targeting Recurrent High Grade Serous Ovarian Carcinomas (HGSOC)
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Birinapant (Primary) ; Carboplatin; Paclitaxel
- Indications Endometrial cancer; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Proof of concept; Therapeutic Use
- 05 Dec 2017 Planned End Date changed from 30 Nov 2020 to 1 Feb 2021.
- 05 Dec 2017 Planned primary completion date changed from 1 Nov 2019 to 1 Feb 2020.
- 05 Dec 2017 Planned initiation date changed from 1 Dec 2017 to 1 Feb 2018.